Targeted In Vivo Loading of Red Blood Cells Markedly Prolongs Nanocarrier Circulation

Dual Affinity to RBCs and Target Cells (DART) Enhances Both Organ- and Cell Type-Targeting of Intravascular Nanocarriers

(2022) Laura T. Ferguson et al.   ACS Nano

Engineered red blood cells as an off-the-shelf allogeneic anti-tumor therapeutic

(2021) Xuqing Zhang et al.   Nature Communications

Red blood cells: The metamorphosis of a neglected carrier into the natural mothership for artificial nanocarriers

(2021) Patrick M. Glassman et al.   ADVANCED DRUG DELIVERY REVIEWS

Combating Complement's Deleterious Effects on Nanomedicine by Conjugating Complement Regulatory Proteins to Nanoparticles

(2021) Zhicheng Wang et al.   ADVANCED MATERIALS

Molecularly Engineered Nanobodies for Tunable Pharmacokinetics and Drug Delivery

(2020) Patrick M. Glassman et al.   BIOCONJUGATE CHEMISTRY

Vascular Drug Delivery Using Carrier Red Blood Cells: Focus on RBC Surface Loading and Pharmacokinetics

(2020) Patrick M. Glassman et al.   Pharmaceutics

The dose threshold for nanoparticle tumour delivery

(2020) Ben Ouyang et al.   NATURE MATERIALS

Reprogramming the rapid clearance of thrombolytics by nanoparticle encapsulation and anchoring to circulating red blood cells

(2020) Mohit Pratap Singh et al.   JOURNAL OF CONTROLLED RELEASE

Red blood cell-hitchhiking boosts delivery of nanocarriers to chosen organs by orders of magnitude

(2018) Jacob S. Brenner et al.   Nature Communications

Nanoparticle Properties Modulate Their Attachment and Effect on Carrier Red Blood Cells

(2018) Daniel C. Pan et al.   Scientific Reports

Vascular targeting of radiolabeled liposomes with bio-orthogonally conjugated ligands: single chain fragments provide higher specificity than antibodies.

(2018) Elizabeth D Hood et al.   BIOCONJUGATE CHEMISTRY

Targeting thrombomodulin to circulating red blood cells augments its protective effects in models of endotoxemia and ischemia-reperfusion injury

(2017) Ronald Carnemolla et al.   FASEB JOURNAL

Engineered erythrocytes covalently linked to antigenic peptides can protect against autoimmune disease

(2017) Novalia Pishesha et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

Red blood cells: Supercarriers for drugs, biologicals, and nanoparticles and inspiration for advanced delivery systems

(2016) Carlos H. Villa et al.   ADVANCED DRUG DELIVERY REVIEWS

Delivering Nanoparticles to Lungs while Avoiding Liver and Spleen through Adsorption on Red Blood Cells

(2013) Aaron C. Anselmo et al.   ACS Nano

Minimal "Self" Peptides That Inhibit Phagocytic Clearance and Enhance Delivery of Nanoparticles

(2013) P. L. Rodriguez et al.   SCIENCE

Targeting recombinant thrombomodulin fusion protein to red blood cells provides multifaceted thromboprophylaxis

(2012) S. Zaitsev et al.   BLOOD

Sustained thromboprophylaxis mediated by an RBC-targeted pro-urokinase zymogen activated at the site of clot formation

(2010) S. Zaitsev et al.   BLOOD

Improving Protein Pharmacokinetics by Engineering Erythrocyte Affinity

(2010) Stephan Kontos et al.   MOLECULAR PHARMACEUTICS

Targeting of a Mutant Plasminogen Activator to Circulating Red Blood Cells for Prophylactic Fibrinolysis

(2009) S. Zaitsev et al.   JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS